Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

340 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cost-effectiveness of low-dose colchicine after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT).
Samuel M, Tardif JC, Khairy P, Roubille F, Waters DD, Grégoire JC, Pinto FJ, Maggioni AP, Diaz R, Berry C, Koenig W, Ostadal P, Lopez-Sendon J, Gamra H, Kiwan GS, Dubé MP, Provencher M, Orfanos A, Blondeau L, Kouz S, L'Allier PL, Ibrahim R, Bouabdallaoui N, Mitchell D, Guertin MC, Lelorier J. Samuel M, et al. Among authors: roubille f. Eur Heart J Qual Care Clin Outcomes. 2021 Sep 16;7(5):486-495. doi: 10.1093/ehjqcco/qcaa045. Eur Heart J Qual Care Clin Outcomes. 2021. PMID: 32407460 Free PMC article. Clinical Trial.
Colchicine: an old wine in a new bottle?
Roubille F, Kritikou E, Busseuil D, Barrere-Lemaire S, Tardif JC. Roubille F, et al. Antiinflamm Antiallergy Agents Med Chem. 2013;12(1):14-23. doi: 10.2174/1871523011312010004. Antiinflamm Antiallergy Agents Med Chem. 2013. PMID: 23286287 Review.
Anti-inflammatory drugs and the heart.
Roubille F, Tardif JC. Roubille F, et al. Antiinflamm Antiallergy Agents Med Chem. 2013;12(1):2. doi: 10.2174/1871523011312010002. Antiinflamm Antiallergy Agents Med Chem. 2013. PMID: 23330990 No abstract available.
Emerging anti-inflammatory therapies for atherosclerosis.
Roubille F, Kritikou EA, Roubille C, Tardif JC. Roubille F, et al. Among authors: roubille c. Curr Pharm Des. 2013;19(33):5840-9. doi: 10.2174/13816128113199990351. Curr Pharm Des. 2013. PMID: 23438958 Review.
340 results